{"name":"Rapamycin Holdings Inc.","slug":"rapamycin-holdings-inc","ticker":"","exchange":"","domain":"rapamycin.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPMUljUWpVSlE5aHRXbzBGNGdZSWdHVXVySVczb3Y4Zm9mUlloTGFNVjd6dFVrWktRTHkwYmNvSnZsNG10ZUxvV3RmODhOaU1Cd2VQaUJsczlhWTVmdTJJSXpEZW1DQS1GTXNsTS1CQm9kb1FiUm9rTTF1QjZlLWJ4QW9zWjM3ZEdiRkJuU2NBYWhzUkxyM0tWNWF4NWtENTNkemsySW1GTGQzTktMSmlpOVJjVFh6dUNtbXIwRWNDYnlGa0RCZkNGVmlmdFUyMEZ1SzFPZFM4TVdGTlliVUMzRlNqNlp4VlpDeGZwS0x5SQ?oc=5","date":"2026-03-31","type":"pipeline","source":"minichart.com.sg","summary":"Palvella Therapeutics QTORIN Rapamycin: Novel Treatment Advancements for Rare Skin Diseases and Vascular Malformations - minichart.com.sg","headline":"Palvella Therapeutics QTORIN Rapamycin: Novel Treatment Advancements for Rare Skin Diseases and Vascular Malformations","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-30","type":"pipeline","source":"simplywall.st","summary":"Palvella Hire Highlights QTORIN Launch Plans And Deep Rare Skin Focus - simplywall.st","headline":"Palvella Hire Highlights QTORIN Launch Plans And Deep Rare Skin Focus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQa0JNemwxZFFpLVk4QXI4TmdqdlhYa1NISnZyR0hmV3JDTzBsN1lDOFdNdUpZRjFKZHZxZVM3N2p2T3ZQTXBaMlJFMFE2Uml3eGhEXzdlaXZXTTlaenhHMHFrZmFOTHpFNXR6UkhueHZJN09FRmc3dGhBREpGck5oUGlyYjZESlZyYXVOQ2NnTGZMc2gtUXV1MWVSVWVudUdIVUh6TTBqUmQ?oc=5","date":"2026-03-27","type":"pipeline","source":"Stock Titan","summary":"Biodexa releases audited preliminary 2025 results for investors - Stock Titan","headline":"Biodexa releases audited preliminary 2025 results for investors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPNUh2X0xJX1J3d2ZFY0dWdjhlVGZvN3F0V1FVNkNpQWlrdndfM1VxQV9ieXc3bnJ3RzNpV0dnRXE0UFBvanc3dE5hNEZyUXN0RWxLX25KS1BkeTg5Vm1JeUVxSkxwTlYyUXlNcy01bGtZV0ticzJncVJTdmdVcnNBb18yUmV4aklWRGgwWGJaMlctSk5FN29ZbVR5R1dPOG5MWnlYaHZ1cXg?oc=5","date":"2026-03-23","type":"deal","source":"Yahoo Finance","summary":"Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group - Yahoo Finance","headline":"Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPVlBLczRXTlhqVVhEUi1sWVQ1MHY5ZTJtOVJxVnE2QWVaZmdqdjkwVVR3VkR0YVVqR0h0emNGZ3U5ZnRrTUxzUEF1WjkyalFQQV9kMEx5R1dCQ1BsM2ZWVG1zbHhwU3E1SHo3WVk1Rk5scG1PSkE2emNXVVpsUld5Sl95MDdwWWR4RWNlQW40b0dwMFNLajJRLWh5c3dVZw?oc=5","date":"2025-11-11","type":"pipeline","source":"Yahoo Finance","summary":"Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies - Yahoo Finance","headline":"Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNeWMyZVV6ZjZUaEVvdGtvZnVra2lrd2R4eDdtVjc4c0FqcEM1NHpJaHVNMk5SbnE3UHV5UGdVRU5NclhQOHVPdXhwZkNiYkZIMEQtTXpfZ05mQnhzRDBVU3k3NFBSbFNlcU9laFBnZ0RnRWo0b2tZLUF1T00yd0xVbXQ3cTJaUXdCRmRIb08zeTdDWUZuVTd6SmFES0kwRWNKZEZKWFNCQQ?oc=5","date":"2025-09-08","type":"trial","source":"newswire.com","summary":"Biodexa Moves Into Phase 3 With eRapa For FAP With First Patients Enrolled - newswire.com","headline":"Biodexa Moves Into Phase 3 With eRapa For FAP With First Patients Enrolled","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNa3FsWndlUWdRc2VhZ0FwQ2tIYmhkelp0bG1Ib29kT2FuVjNoeDRLem42SUFnTXlsNU5wME5FblI3WjJEYWVfY3lESzFqM01kaXQzMU9XRWZkb2swb25FVFFEQTN6eW1qQ0UyOVA2U1pOVGFiNk5wUC1PcFFYc1NWVHdwc2RWVU5STGRYRFdFNVptTGpKd2FIY1B4ZGNNRHVwUU1INkxZblFxNFpZVVNmM0tyY1lFTmFHNnVrREZ5VFZPblR5VlFJMER5aTBJelJLWldjMG5LdVVKejhkS01QX2h3Nm4?oc=5","date":"2025-07-28","type":"trial","source":"ACCESS Newswire","summary":"How Biodexa Is Racing To Get Its Phase 3 Program in FAP Under Way And Gain First-Mover Advantage in a $7Bn Addressable Market - ACCESS Newswire","headline":"How Biodexa Is Racing To Get Its Phase 3 Program in FAP Under Way And Gain First-Mover Advantage in a $7Bn Addressable M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBXR0NnbDdILVJfeVQ1TVpZMnc3eHl3VTh2cG1VQnpoY091aDQzMjd3RmxEMm01WDAxVnpPNndtdnJnamdJLVk2NTVTRDQ0Zkl4NE84?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"BDRX Stock Price, News & Analysis - Stock Titan","headline":"BDRX Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE00d3JWc2NFV21jb1ZDOHFhUUYxczY1NUdyRngwWDBYcUw4b2VjYWxQVzlhUDgxdmFwMEthNFZEdmtxZ1BiaThwd2RBTlJoNmY1OEtBa3dSbmkta3pNaHMwZFRKR3pCMDl5eXFwUw?oc=5","date":"2024-09-25","type":"pipeline","source":"MedPage Today","summary":"Anti-Pharma Bus Tour; Rapamycin for Longevity? Hospital Forgives Debt After Pressure - MedPage Today","headline":"Anti-Pharma Bus Tour; Rapamycin for Longevity? Hospital Forgives Debt After Pressure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9WLXR5LWV4cWprZUpHei13U3pNVEZzQTBpT3pXRjFiMlJWNTlOUlRmXzR6S1hLT01uZGctdkRuMFNNSUZ5cWFnQTB5YkZyMkhBUThjYVNPVnJPd2lKS3Nj?oc=5","date":"2023-10-13","type":"pipeline","source":"Nature","summary":"Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques - Nature","headline":"Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1IWW1VRm5WZURDRHg5cElHSFcyc21XQnV0ci11VXZJM1lUdUhzbFNTbTBMdFFLdkRzSmFXc3drVzduczAtLXNQMVJDdzdYOHlKVjJkN2k5ZFNlT2tSVTk0?oc=5","date":"2023-08-17","type":"trial","source":"Nature","summary":"Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis - Nature","headline":"Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPdmlCV2NhaHpMbVNXY0tjUjAwRFNzcE5UOUI3WkNCNHB5NnhRMzhiN3dsWHFRcjJ6SjhSa19wdlI1Q0IwOWRjSkE2NnR2VjBfcVF1ZWNSVFQ4aXRJV3ZjSWUzbVpEamtUOExaMzBubUxXVW93MEtDQzdBNko0eFc0aTdaT2RuaDZFUFJ3SzhFZ01zQjVlRGNmeFlWMUg5NDAydko2ZmZPcmZyaEx1YlJLYWptWG1nQQ?oc=5","date":"2017-08-30","type":"regulatory","source":"BioPharma Dive","summary":"Aveo wins European approval for cancer drug, triggering milestone payment - BioPharma Dive","headline":"Aveo wins European approval for cancer drug, triggering milestone payment","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}